Care Management & Coordination · Healthcare & Life Sciences
Should you build or buy Post-Acute Referral & Network Management?
Post-Acute Referral & Network Management software helps hospitals, health systems, and post-acute care organizations manage patient referrals, track network partner performance, and use commercial claims data to identify referral patterns and growth opportunities. It connects discharge teams to post-acute providers and gives network managers visibility into referral volume, quality metrics, and census trends.
The build-vs-buy decision for Post-Acute Referral & Network Management turns on whether an organization can independently access the commercial claims data that powers referral intelligence, and how much custom relationship scoring and intake automation on top of that data is worth building; the specifics decide it, and the calculus has been stable because the licensed data moat isn't shrinking.
Build it, buy it, or bridge?
When building makes sense
Building makes sense when an organization has licensed commercial claims data independently and wants to build relationship scoring and intake automation that reflects its specific geography, payer mix, and preferred partner profiles in ways the vendor's standardized model doesn't capture. AI-driven referral matching is genuinely buildable on top of licensed claims feeds, and for post-acute organizations with significant data science capacity, custom intake decisioning that learns from their own referral outcomes can outperform a vendor's generic model. The organizations best positioned to build are those that have already invested in claims data infrastructure for other purposes, like population health or value-based contract management, and can extend that investment into referral intelligence. This is an augmentation case, not a replacement case. The claims data layer itself, billions of CMS and commercial payer records, cannot be independently constructed, so the build path always starts with data licensing.
When buying makes sense
Buying makes sense whenever referral intelligence is needed immediately and your organization doesn't have licensed claims data infrastructure already in place. Platforms like Trella Health, CarePort, and Olio Health have spent years and substantial resources licensing and integrating CMS and commercial payer claims records across geographies. That dataset is what makes network benchmarking accurate and referral routing trustworthy across payer types. For post-acute providers where census directly drives revenue, the financial stakes of getting referral intelligence right are high enough that the time-to-value argument alone justifies buying. The buy case also holds for hospital discharge teams that need real-time network visibility and automated clinical packet transmission to post-acute partners without building those integrations from scratch. Vendor pricing typically scales with facility count or referral volume, which keeps the ongoing cost proportional to the value received.
The desk read
The commercial claims data that powers referral network intelligence, billions of CMS and commercial payer records that platforms like Trella Health, CarePort, and Olio Health have licensed, isn't a dataset any internal team can replicate. It's the reason referral intelligence is accurate across geographies and payer types, carrying real financial weight for post-acute providers where census is directly tied to which referring hospitals your team has relationships with. For those providers, that benchmarking layer matters significantly.
The build case gets interesting on top of that data layer, not beneath it. Organizations that have licensed claims feeds from a data vendor can build custom relationship scoring and intake automation tailored to their geographic market and payer mix. AI-driven referral matching and automated intake decisioning are advancing quickly, and the organizations best positioned to build are those that own their relationship data and have the analytics capacity to put claims intelligence to work. Buying the platform earns its keep as long as licensed claims data remains the core advantage. Augmenting with custom models on top is where strategic ownership makes the most sense. Rovicare and Real Time Medical Systems serve different parts of the referral and care coordination workflow.
Frequently asked
What is Post-Acute Referral & Network Management?
Post-Acute Referral & Network Management software helps hospitals, health systems, and post-acute care organizations manage patient referrals, track network partner performance, and use commercial claims data to identify referral patterns and growth opportunities. It connects discharge teams to post-acute providers and gives network managers visibility into referral volume, quality metrics, and census trends.
When does building Post-Acute Referral & Network Management make sense?
Building is realistic for organizations that already have licensed claims data feeds and data science capacity, and want custom relationship scoring tuned to their geography and payer mix. AI-assisted intake decisioning is buildable on that foundation, but the claims data layer itself requires licensing, not construction.
When does buying Post-Acute Referral & Network Management make sense?
Buying makes sense whenever you need immediate network intelligence without independently licensed claims data. The commercial payer datasets vendors have assembled are what make referral benchmarking accurate, and replicating them is not a realistic option for most post-acute organizations.
What are the main Post-Acute Referral & Network Management vendors?
Representative vendors include Trella Health, Rovicare, CarePort (WellSky), Olio Health. B4 Pro scores the full set.